Gelong Exchange on October 9th, FDA of the United States allowed on Friday.$GlaxoSmithKline (GSK.US)$Boostrix vaccine is used in the third trimester of pregnancy to prevent pertussis in infants under two months of age. FDA said that when a pregnant woman is vaccinated with Boostrix during pregnancy, it strengthens the mother's antibodies, which are transferred to the developing baby. The vaccine was first approved by health regulators in 2005 for teenagers between the ages of 10 and 18 as a single-dose vaccine against tetanus, diphtheria and pertussis, and later allowed in adults and people over the age of 65. According to the US Centers for Disease Control and Prevention (CDC), 4.2 per cent of pertussis (a common respiratory disease) reported in the United States in 2021 were infants under six months old.
美国FDA允许孕妇在妊娠晚期使用葛兰素史克Boostrix疫苗 以预防两个月以下婴儿百日咳
FDA in the United States allows pregnant women to use GlaxoSmithKline PLC Boostrix vaccine in the third trimester of pregnancy to prevent pertussis in infants under two months old.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.